medialipid, intralipid versus medialipid) at each time point should be described (5) . Second, as the baseline MAP (MAP b ) was higher in the lipid emulsion (intralipid or medialipid) groups than in the control group (Table 1) , even though the MAP of T 0 was not significantly different, it is natural that MAP at T 15 , T 20 , and T 30 was higher in the lipid emulsion (intralipid or medialipid) groups than in the control group (1). In addition, the results obtained from the same statistical analysis method may be different depending on the absolute or relative value of MAP. Thus, data description using the percentage change of baseline MAP induced by verapamil infusion followed by lipid emulsion infusion may be more reasonable. Third, although according to Akgün Şahin et al. the rats were randomly assigned to one of three groups, MAP b was higher in the lipid emulsion (intralipid and medialipid) groups than in the control group (Table 1) (1). Thus, if more careful randomization among the three groups were performed, the possibility of a difference in MAP b between the control and lipid emulsion (intralipid or medialipid) groups would be reduced.
In conclusion, I think that this study contributes to data demonstrating lipid emulsion treatment as a nonspecific antidote to intractable cardiovascular collapse induced by a toxic dose of verapamil. However, if the above suggestions including a detailed description of the statistical method used for multiple comparisons following the linear mixed model, careful randomization, and percentage change of baseline MAP would be considered, this study would be improved and more informative for its readers.
To the Editor,
We would like to thank Sohn for reading and evaluating our article entitled "Therapeutic effects of intralipid and medialipid emulsions in a rat model of verapamil toxicity", published in the Turkish Journal of Medical Sciences. We value the views regarding the statistical evaluation of our article. Although randomization was conducted in our study, the MAP b value was found to be lower in the control group than in the other two study groups. In this case, if we had denoted the rate of change in MAP values in percentage, as suggested by Sohn, the degree of significance among the groups would have been determined better. Furthermore, when the MAP values' change in time is considered, it is observed that the values in the control group decrease in time and remain low and that MAP values in the intralipid and medialipid groups decrease down to T 5 and T 10 , respectively, but in contrast to the control group, they increase (please see Table 1 in the original article). 
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